Literature DB >> 6289774

Hypercalcemia and primary hepatic tumors.

W A Oldenburg, J A van Heerden, G W Sizemore, C F Abboud, P F Sheedy.   

Abstract

We treated a case of hypercalcemia and primary liver tumor and reviewed a series of such cases treated at the Mayo Clinic (Rochester, Minn). Primary tumor of the liver was diagnosed in 192 patients (152 had hepatocellular carcinomas; 40, cholangiocarcinomas) between 1969 and 1980. Hypercalcemia of unknown cause was found in eight patients with hepatocellular carcinoma (5.3%) and seven with cholangiocarcinoma (17.5%). Five hypercalcemic patients had serum immunoreactive parathyroid hormone values consistent with ectopic hyperparathyroidism. An additional five patients had high serum calcium, low phosphate, and low chloride concentrations that met Lafferty's criteria for pseudohyperparathyroidism. Our results suggest that hypercalcemia associated with primary hepatic tumors is relatively common, and incidences vary according to the type of primary tumor. Hypercalcemia may be controlled when surgical excision of the primary tumor is possible.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6289774     DOI: 10.1001/archsurg.1982.01380340077018

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  11 in total

1.  Combined hepatocellular-cholangiocarcinoma producing parathyroid hormone-related protein: report of a case.

Authors:  Michinori Matsumoto; Shigeki Wakiyama; Hiroaki Shiba; Takeshi Gocho; Takeyuki Misawa; Yuichi Ishida; Mariko Itsubo; Masafumi Suzuki; Katsuhiko Yanaga
Journal:  Surg Today       Date:  2013-09-08       Impact factor: 2.549

2.  Hypercalcaemia associated with chronic viral hepatitis.

Authors:  J F Cadranel; J Cadranel; C Buffet; O Ink; G Pelletier; E Bismuth; J P Etienne
Journal:  Postgrad Med J       Date:  1989-09       Impact factor: 2.401

Review 3.  Response of paraneoplastic syndromes to antineoplastic therapy.

Authors:  M Markman
Journal:  West J Med       Date:  1986-05

4.  Transcatheter arterial chemo-embolization for humoral hypercalcemia of hepatocellular carcinoma.

Authors:  K Suzuki; N Kono; A Ono; Y Osuga; H Kiyokawa; I Mineo; Y Matsuda; S Miyoshi; S Kawata; Y Minami
Journal:  Gastroenterol Jpn       Date:  1988-02

5.  Epidemiology and prognosis of paraneoplastic syndromes in hepatocellular carcinoma.

Authors:  Pik Eu Chang; Wai Choung Ong; Hock Foong Lui; Chee Kiat Tan
Journal:  ISRN Oncol       Date:  2013-12-11

6.  Cholangiocarcinoma presenting with hypercalcemia and thrombocytopenia.

Authors:  Muharrem Battal; Bünyamin Gürbulak; Ozgür Bostanci; Müveddet Banu Yılmaz; Yasar Ozdenkaya; Oguzhan Karatepe
Journal:  Case Rep Med       Date:  2014-06-15

7.  Syndrome of inappropriate anti-diuretic hormone secondary to non-cirrhotic primary hepatocellular carcinoma.

Authors:  Sherif Eltawansy; Johnson Gomez; Kenneth Liss; Noel Nivera; Mark Babyatsky
Journal:  Am J Case Rep       Date:  2015-01-23

8.  Hypercalcemia related to cholangiocellular carcinoma.

Authors:  Erhan Onalan
Journal:  Clin Case Rep       Date:  2019-07-01

9.  Hypercalcemia in a patient with cholangiocarcinoma: a case report.

Authors:  Ioannis D Xynos; Stavros Sougioultzis; Athanasios Zilos; Konstantinos Evangelou; Gregorios S Hatzis
Journal:  Int Arch Med       Date:  2009-10-30

10.  Two cases of humoral hypercalcemia of malignancy in metastatic cholangiocarcinoma.

Authors:  Seungtaek Lim; Jungwoo Han; Kyeong Hye Park; Won Jai Jung; Yong Kang Lee; Ara Choi; Young Jae Kim; Jong-Chan Lee; Hye Jin Choi
Journal:  Cancer Res Treat       Date:  2013-06-30       Impact factor: 4.679

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.